What GLP-1 sellers do not publish

How this was counted

61 sellers, each read from its own public pages, September 2026. A seller counts as publishing something only if you can see it: terms buried in a page’s code that never appear on screen count as absent, and 4 of the 61 sellers whose figure states what it buys are in exactly that state for their cancellation terms. Terms behind a tab or an accordion you can open do count, because you can reach them.

This site holds 117 sellers in all. The other 56 publish 150 monthly prices between them and not one of those figures says what dose it buys, so none of the four counts above covers them: their cancellation terms were never opened and their figures have no stated basis. Counting them either way would put a number against sellers nobody looked at for it. Each of the 56 has its own page saying what was read and what was not, under every seller we have read.

No provider is named on this page and no link on it is paid. Every finding below is stated per seller, with its read date, on that seller’s own page under every seller we have read.

The pharmacy that would dispense

55 of the 61 sellers whose figure states what it buys never name the pharmacy that would dispense the prescription. 6 do.

It is the single most common silence on this roster, and it is the one a reader can do least about. The seller you buy from is usually not the entity that compounds or ships the drug; without the pharmacy’s name there is nothing to look up — no state board record, no inspection history, no way to tell whether two sellers at very different prices are shipping from the same facility.

6 of the 61 sellers whose figure states what it buys appear to share an operator with another seller on this roster — the same corporate footprint behind two brand names. That is recorded per seller rather than asserted here, because a shared registrant is a candidate and not a finding.

Compounded or branded

34 of the 61 sellers whose figure states what it buys do not state, beside the price, whether the drug being sold is compounded or the branded product. 27 say compounded. None on this roster says branded.

The two are not the same product and they are not regulated the same way. A compounded drug is prepared by a pharmacy rather than approved by the FDA as a finished product, and the difference is the reason a figure can be a fraction of the branded list price. A page that prints the figure and not the class has published the number that persuades and withheld the fact that explains it.

This site treats “the page does not say” as a value rather than a gap: it is what the seller published, and it is selectable as its own filter on every board.

The dose schedule

55 of the 61 sellers whose figure states what it buys do not print the titration steps their own patients follow. 6 do.

Every GLP-1 starts low and steps up, and where a seller charges by dose the schedule is also the price schedule — so a reader who cannot see the steps cannot work out what month four costs. What the four FDA-approved labels set as the escalation is published on this site with no provider named and no paid link, which is the closest a reader can get when the seller will not say.

How to cancel

36 of the 61 sellers whose figure states what it buys publish no cancellation terms a reader can reach. 25 do. Of the ones that do not, 4 keep the terms in the page’s code without ever showing them — text no reader can see, which counts here as unpublished.

38 of the 61 sellers whose figure states what it buys claim a reader can cancel at any time. 16 of those publish no terms behind the claim — no route to cancel, no notice period, no refund position. That is not a silence; it is a promise with nothing under it.

What they do publish

All 61 of the 61 sellers whose figure states what it buys publish a figure whose basis they state — what the money buys, in the seller’s own words — which is what this site requires before it will print a price at all. 60 of those figures are readable on a public page; one is published only inside an intake, and is marked as such on the board.

53 of the 61 sellers whose figure states what it buys state that the medication itself is included in the figure; 8 do not. 98 of the 61 sellers whose figure states what it buys carry the figure on a page a reader can reach directly, rather than only on a home page.

These are the four things this site scores. What each one is worth, and why, is on how we grade. The category scores describe disclosure, not medical quality. No overall provider ranking is published.

The other findings

Each one says how many sellers it counted, and the counts differ on purpose: a question can only be asked of the sellers who published enough to answer it.

• How many sellers publish a price

  What happened when the pages of every GLP-1 seller we could find were opened and read: how many published a figure at all, and how many published one that can be compared.

  Counted over 588 sellers whose pages were opened.

• What drug the price is for

  Whether a published GLP-1 figure says which drug it prices, and how often the number sits on a page that never names one.

  Counted over 3018 published figures across 408 sellers.

• Compounded or branded

  How often a seller says, beside the figure, whether the drug is compounded or the FDA-approved product — and the one case where it almost always does.

  Counted over 3018 published figures across 408 sellers.

• The tirzepatide premium

  What the same seller charges for tirzepatide against semaglutide — and why most sellers who sell both do not publish a pair a reader can put side by side.

  Counted over 46 sellers publishing a figure for both molecules.

• What a price buys, by dose

  Whether a GLP-1 price changes with the dose, and how many sellers publish a figure that states which dose it buys at all.

  Counted over 61 of 117 sellers on this roster.

Where the same records are compared

One board per buying decision. Each is the same table with the columns that decision needs, under its own dated and counted title.

• Semaglutide providers55 listed

  Compare semaglutide plans, pharmacy details and cancellation terms.

• Tirzepatide providers52 listed

  Compare tirzepatide plans, pharmacy details and cancellation terms.

• Providers that publish a price before the intake60 listed

  See providers that show medication prices before the intake.

• GLP-1 providers with a published price, compared60 listed

  Compare advertised prices, plan commitments and what’s included.

• GLP-1 providers for readers paying cash53 listed

  Compare plans whose published price includes medication.

• GLP-1 telehealth providers61 listed

  Compare GLP-1 prescribers, pharmacy details, care and cancellation terms.

Every board above was read September 2026 and carries its own dated, counted title.

What the FDA labels say

The four sub-scores on this site measure what a seller publishes — not the drug. What each drug is approved to treat, how its dose escalates and who should not take it is read from the FDA-approved prescribing information, with no provider named and no paid link.

• First-year GLP-1 costsresearch guide

  A low monthly headline does not tell you what a year of treatment will cost. Compare the same medication and service package, then separate the total you expect to spend from the amount you must pay before treatment begins.

• Cancellation and refundsresearch guide

  Canceling future membership charges, stopping an upcoming medication order and requesting a refund are three different requests. Get a written answer for each one that applies to you.

• Insurance denial documentsresearch guide

  The next step depends on why coverage was denied. A missing document, a formulary restriction and an excluded benefit are different problems. Start with the written decision before paying someone to submit another request.

• Savings and cash-pay eligibilityresearch guide

  A manufacturer savings card and a self-pay offer can have different eligibility rules, even for the same medicine. Match the offer to your coverage and exact product before using its advertised price in your budget.

• Verify your GLP-1 pharmacyresearch guide

  The website taking your payment, the clinician prescribing and the pharmacy dispensing may be different businesses. Identify each one. A recognizable brand or a reassuring badge does not tell you who will fill the prescription.

• Changing GLP-1 providersresearch guide

  Before ending your current service, establish what the new practice needs, what it will charge and when it can evaluate you. Transferring your records does not guarantee that another clinician will continue the same prescription.

• Weight regain after stoppingresearch guide

  Weight regain occurred after treatment withdrawal in studies of semaglutide and tirzepatide. The findings support planning follow-up and affordability before an interruption, but they do not predict exactly what will happen to one person.

• Semaglutide vs tirzepatideresearch guide

  What the four FDA-approved labels say each molecule is, what each is approved to treat, and where the two differ.

• How they workresearch guide

  The receptor each molecule switches on, what the labels say that does to appetite, blood sugar and the stomach, and why one dose lasts a week.

• Is Ozempic insulin?research guide

  What the Ozempic label calls semaglutide, how that differs from insulin, and where insulin appears on these labels as a separate medicine.

• Zepbound vs Ozempicresearch guide

  Four brand names, two molecules and two kinds of approval: which of these products are the same drug, and what each one is actually approved to do.

• Dose escalation schedulesresearch guide

  The starting dose, the escalation interval and the maximum dose each label sets, and why they are not interchangeable.

• Side effect ratesresearch guide

  What each label reports for nausea, vomiting, diarrhea and constipation — and the sentence every label prints above those numbers.

• Hair lossresearch guide

  Which labels report hair loss, the rate against placebo where a trial measured it, and why two of them put no number on it.

• Fatigue and tirednessresearch guide

  Which labels list fatigue, the rate against placebo where a trial measured it, and what each label counts as fatigue.

• Missed dose rulesresearch guide

  The window each label gives for a late dose, and the minimum gap it requires when the injection day changes.

• Drug interactionsresearch guide

  Insulin and sulfonylureas, oral medications, and the oral-contraceptive precaution that appears on two of these four labels and not the other two.

• Buying one onlineresearch guide

  The agency's own warning signs for a telehealth GLP-1 seller, its 28-day vial rule, and what it says about drugs that arrive warm.

• Zepbound by doseresearch guide

  What each Zepbound dose achieved in the trials printed in its label, what the label says about choosing a maintenance dose, and what the higher doses cost in side effects.

• Zepbound at 3 monthsresearch guide

  What does the Zepbound label report about three-month weight loss and maintenance dosing?

• Injecting tirzepatideresearch guide

  The injection sites, the rotation rule and the steps for the single-dose pen, the KwikPen and the vial and syringe, exactly as the FDA-approved Instructions for Use give them.

• Refrigeration and storageresearch guide

  How cold each pen is kept, how many days it can spend at room temperature, and what the labels say about heat and freezing.

• Who should not take oneresearch guide

  The boxed warning every one of these labels carries, the two contraindications, and which warnings appear on which product.